| Body na spoluautora | Body za publikaci pro MU | Odkaz ISVaV | | 36,41 | 145,65 | Memantine Inhibits CYP 2D2 In Rat Liver-Comparison With Inhibitory Influence Of Fluoxetine
|
| 0,00 | 0,00 | VPLYV BUPROPIONU A POHLAVIA NA METABOLICKÚ AKTIVITU PEČEŇOVEJ IZOFORMY CYP2D2 V PREKLINICKOM EXPERIMENTE
|
| 0,00 | 0,00 | Gender-dependent influence of bupropion on the activity of hepatic cytochrome P450 2D2 in rats
|
| 3,09 | 12,37 | Evaluation of the activity of P450 enzymes in rats: use of the single marker or combined drug administration.
|
| 0,70 | 2,81 | Vliv metamfetaminu na biotransformační procesy cytochromu P450
|
| 0,47 | 2,81 | Změny působení metamfetaminu při současném užití antidepresiva fluoxetinu v preklinických modelech
|
| 0,00 | 0,00 | Stanovení diklofenaku a 4-hydroxydiklofenaku jako markeru metabolické aktivity CYP2C9
|
| 0,00 | 0,00 | RYCHLÉ HPLC STANOVENÍ FENOTYPU CYP 1A, 2C A 3A Z PERFUZÁTU IZOLOVANÝCH JATER
|
| 0,00 | 0,00 | RYCHLÉ HPLC STANOVENÍ FENOTYPU CYP 1A, 2C A 3A Z PERFUZÁTU IZOLOVANÝCH JATER POTKANA
|
| 0,67 | 4,03 | Efekt fluoxetinu na biodegradaci metamfetaminu u metamfetaminové závislosti
|
| 1,14 | 8,00 | Effect of methamphetamine on pharmacokinetics of dextromethorphan and midazolam.
|
| 1,14 | 8,00 | Feet of methamphetamine on pharmacokinetics of dextromethorphan and midazolam in rats.
|
| 12,86 | 77,18 | Effect of fluoxetine on methamphetamine biodegradation in methamphetamine dependence
|
| 3,60 | 21,60 | Effect of acute and sub-chronic administration of methamphetamine on activity of CYP2D in isolated perfused rat liver.
|
| 3,60 | 21,60 | Effect of acute and repeated administration of methamphetamine on the activity of CYP2D in isolated perfused rat liver
|
| 3,83 | 22,95 | Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver
|
| 4,68 | 14,04 | Farmakokinetika
|
| 0,00 | 0,00 | Determination of midazolam and its metabolites in rat plasma and perfuse medium by HPLC
|
| 0,00 | 0,00 | Determination of nifedipine as a probe substrate of cytochrome P450 3A1/2 activity in rats
|
| 0,00 | 0,00 | The effect of polyphenolic extract from grape byproducts on selected biochemical characteristics in rats
|
| 0,00 | 0,00 | HPLC STANOVENÍ MIDAZOLAMU A JEHO METABOLITŮ V PLAZMĚ A PERFUZNÍM MEDIU
|
| 1,12 | 5,62 | The influence of gender on metabolic activity of enzymatic system of cytochrome P450 in the model of isolated perfused rat liver.
|
| 1,56 | 9,36 | Možnosti aplikace testování aktivity CYP2D6: přehled dosavadních výsledků více než desetileté spolupráce genetiky, farmakologie a psychiatrei
|
| 0,00 | 0,00 | Modulating effects of CB1 agonist methananadamide on the activity of CYP450 isoenzymes in rat
|
| 1,40 | 5,62 | Trans-resveratrol enhances sex differences in CYP1A2 metabolic activity in rats
|
| 4,04 | 16,15 | The Influence of Trans-resveratrol and Quercetin on the Activity of CYP1A2 in Rat
|
| 0,00 | 0,00 | VLIV POLYFENOLICKÝCH LÁTEK NA AKTIVITU ENZYMATICKÉHO SYSTÉMU CYP450
|
| 1,40 | 5,62 | THE INFLUENCE OF CANNABINOID METHANANDAMIDE ON THE ACTIVITY OF HEPATIC CYP2D2 IN RATS
|
| 0,00 | 0,00 | The influence of resveratrol on the activity of hepatic CYP450 isoenzymes in rat
|
| 3,14 | 12,56 | THE INFLUENCE OF POLYPHENOLIC EXTRACTS FROM GRAPE BYPRODUCTS ON THE METABOLIC ACTIVITY OF CYP1A2 IN HYPERCHOLESTEROLAEMIC RATS
|
| 1,40 | 5,62 | THE INFLUENCE OF POLYPHENOLIC EXTRACT FROM ANDRE AND BLAUER PORTUGAISER GRAPE BYPRODUCTS ON THE ACTIVITY OF LIVER CYP1A2 ISOENZYME
|
| 0,00 | 0,00 | HPLC - ED determination of diclofenac and its hydroxylated metabolite as a marker of metabolic activity of CYP2C6 in rats
|
| 3,14 | 12,56 | THE INFLUENCE OF METHANANDAMIDE AND SEX ON THE ACTIVITY OF CYTOCHROME P 450 AS A PREDICTIVE FACTOR OF XENOBIOTICS TOXICITY
|
| 0,00 | 0,00 | The influence of diet on metabolic activity of cytochrome P450
|
| 4,73 | 18,91 | Effect of methamphetamine on cytochrome P450 activity.
|
| 8,43 | 50,56 | HPLC determination of midazolam and its three hydroxy metabolites in perfusion medium and plasma from rats
|
| 19,30 | 77,18 | Gender-dependent influence of bupropion pretreatment on locomotor activity and the activity of hepatic CYP2D2 in rats
|
| 13,59 | 54,36 | Fading of the inhibition of CYP2D6 after paroxetine treatment discontinuation
|
| 4,21 | 8,42 | Aktivita cytochromu P4502D6 při dlouhodobé léčbě paroxetinem ve srovnání se zdravými dobrovolníky
|
| 2,03 | 12,19 | Comparison of serum and urine analyses in CYP2D6 phenotyping for psychiatric purposes
|
| 0,00 | 0,00 | Can methanandamide and gender influence pharmacokinetics of psychoactive drugs?
|
| 22,64 | 90,57 | Study of recombinant cytochrome P450 2C9 activity with diclofenac by micellar electrokinetic capillary chromatography
|
| 0,00 | 0,00 | Simultaneous HPLC determination of markers of metabolic activity of CYP1A2 and CYP2C6
|
| 0,00 | 0,00 | Vliv polyfenolických extraktů z vinných matolin na aktivitu CYP 1A2 u potkanů s hypercholesterolemickou dietou
|
| 0,00 | 0,00 | VPLYV METANANDAMIDU NA AKTIVITU CYTOCHRÓMU P450 AKO PREDIKČNÉHO FAKTORU TOXICITY XENOBIOTÍK
|
Back
(c) Michal Bulant, 2011